Efficacy and Safety of Everolimus As Long-Term Treatment in Japanese Patients With Advanced Pancreatic Neuroendocrine Tumors

被引:0
|
作者
Lee, Lingaku
Igarashi, Hisato
Hijioka, Masayuki
Ueda, Keijiro
Fujiyama, Takashi
Tachibana, Yuichi
Kawabe, Ken
Ito, Tetsuhide
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa2048
引用
收藏
页码:S393 / S393
页数:1
相关论文
共 50 条
  • [21] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    PANCREAS, 2017, 46 (03) : 435 - 435
  • [23] Safety and efficacy of combination of temozolomide and pazopanib in patients with advanced pancreatic neuroendocrine tumors (PNET).
    Nimeiri, Halla Sayed
    Pai, Sachin Gopalkrishn
    Chiorean, E. Gabriela
    Rademaker, Alfred
    Kircher, Sheetal Mehta
    Mulcahy, Mary Frances
    Cohen, Steven J.
    Denlinger, Crystal Shereen
    Sahai, Vaibhav
    Zalupski, Mark
    Berlin, Jordan
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report
    Maia, Manuel C. D. F.
    Lourenco, Delmar Muniz, Jr.
    Riechelmann, Rachel
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (10) : 643 - +
  • [25] Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia Long-term safety and efficacy of fostamatinib
    Kuwana, Masataka
    Tomiyama, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (03) : 356 - 362
  • [26] Everolimus versus placebo in Japanese patients with advanced pancreatic neuroendocrine tumors (pNET): Japanese subgroup analysis of RADIANT-3
    Ito, T.
    Okusaka, T.
    Ikeda, M.
    Tajima, T.
    Kasuga, A.
    Fujita, Y.
    Furuse, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [27] Angiogenic Circulating Biomarkers in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus
    Cella, C. A.
    Spada, F.
    Labanca, V
    Radice, D.
    Rubino, M.
    Zorzino, L.
    Fazio, N.
    NEUROENDOCRINOLOGY, 2017, 105 : 3 - 3
  • [28] Efficacy and Safety of Everolimus in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
    Ambrosio, M. R.
    Guerra, A.
    Lupo, S.
    Bondanelli, M.
    Sartori, S.
    Pansini, G.
    Degli Uberti, E.
    Zatelli, M. C.
    NEUROENDOCRINOLOGY, 2012, 96 : 17 - 18
  • [29] Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis
    Yamada, Satoshi
    Yoshino, Takuya
    Matsuura, Minoru
    Kimura, Masamichi
    Koshikawa, Yorimitsu
    Minami, Naoki
    Toyonaga, Takahiko
    Honzawa, Yusuke
    Nakase, Hiroshi
    INTESTINAL RESEARCH, 2015, 13 (03) : 250 - +
  • [30] Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
    Wiedmann, Marcus W.
    Mossner, Joachim
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 381 - 393